Boston, MA., Could 16, 2022 – OrthoSpineNews –
NanoHive Medical as we speak introduced the enlargement of its patent portfolio with the issuance of patent quantity US11,253,368 B2, Strategies of Designing Excessive X-Ray Lucency Lattice Buildings.
The patent is the sixteenth issued patent for NanoHive, and represents a broad piece of mental property associated to the radiolucency of interbody buildings and the power to observe development in the direction of an interbody fusion. These buildings embrace a wide range of lattices, together with the patented NanoHive Comfortable Titanium lattice, using a rhombic dodecahedron cell construction.
Particularly, the patent covers the design of structural lattices with enhanced radiographic visibility, permitting physicians to extra successfully consider bone development by way of the titanium implant. This design strategy removes the necessity for a standard lateral viewing window and permits extra scaffolding within the implant to assist bony ingrowth and ongrowth. The implant lattice balances structural integrity and porosity whereas maximizing radiolucency.
Different designs geared toward decreasing lattice density have to compensate by rising the thickness and power of implant’s body. A thicker body, together with endplates and vertical struts on the implant’s corners, ends in stress shielding and decreased differentiation of distinction to discern bone development contained in the implant.
“This most up-to-date patent additional validates the Hive know-how, whereas offering worth to each surgeons and sufferers. We’re persevering with to pursue mental property to assist differentiate the Comfortable Titanium® lattice from different designs and implants”, added Ian Helmar, Co-Founder and Vice President of Analysis & Growth at NanoHive Medical, LLC.
NanoHive Medical, LLC is a pioneer and main innovator in 3D printed spinal interbody fusion implants and instrumentation. The corporate’s proprietary, biomimetic Comfortable Titanium® know-how clearly distinguishes their merchandise within the $1.9B spinal interbody fusion system market. The Hive™ portfolio of interbody fusion units present surgeons and their sufferers best biomechanical elastic modulus properties, clear and exact diagnostic imaging functionality, osteoblast cell attraction and integration – all options that result in constantly robust fusion constructs and efficacious scientific experiences.
NanoHive Medical is positioned in Woburn, Massachusetts U.S.A
Contact: Patrick O’Donnell, CEO & President, Patrick.email@example.com
Web site: www.nanohive.com